Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients

NCT07580144 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-05-15

No results posted yet for this study

Summary

This prospective observational study aims to evaluate whether sarcopenia and frailty affect the pharmacodynamic profile of rocuronium in geriatric patients undergoing elective surgery under general anesthesia.

Conditions

Sponsors & Collaborators

  • Konya Meram State Hospital

    lead OTHER

Principal Investigators

  • Betül Kozanhan, M.D. · SBÜ Konya EAH

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-13
Primary Completion
2026-08-01
Completion
2026-08-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07580144 on ClinicalTrials.gov